Amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig’s disease, remains a terrible disease for patients, their families and for doctors trying to help.
Patients typically survive three to five years after diagnosis. During their illness, they become progressively paralyzed. They lose speech, mobility and all independence. This reflects the unstoppable degeneration of motor neurons which pass impulses from the brain and spinal cord to the muscles we use for walking, lifting, swallowing and breathing.
In the face of this reality, people with ALS and their families are living their lives with courage and optimism. They are taking action to change the way medical research is conducted, raise funds, and improve care. They define what it means to have hope.
Inspired by our friends, loved ones, and heroes, Target ALS is taking on the challenge of accelerating development of first effective treatments for ALS.